Poland· PL-100171336

Exforge

A valsartan and amlodipine product containing amlodipinum + valsartanum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 14 of our 19 countries.

ATC C09DB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedExforgeATCC09DB01REGISTER NO.PL-100171336PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Valsartan and amlodipine is registered in 14 of 19 countries.

Countries holding a registration under ATC C09DB01 (valsartan and amlodipine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Valsartan and amlodipine · ATC C09DB01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Amlodipinum + Valsartanum
Manufacturer
Novartis Europharm Limited
Country
Poland (PL)
ATC code
C09DB01
ATC class
Valsartan and amlodipine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990036707
  • gtin
    05909990036776
  • gtin
    05909990036783
  • gtin
    05909990047505

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for valsartan and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valsartan and amlodipine · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Valsartan and amlodipine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartan and amlodipine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amlodipin/Valsartan +pharma, Amlodipin/Valsartan 1a Pharma
  • Belgium · Amlodipine/Valsartan Eg, Amlodipine/Valsartan Krka
  • Bulgaria · Aзбима, Валдипин Дуо
  • Cyprus · Valsimia
  • Czechia · Asbima, Wamlox
  • Germany · Amlo-Valsacor, Amlodipin Hexal Plus Valsartan Hexal
  • Denmark · Amlodipin/Valsartan Stada
  • Estonia · Wamlox
  • Spain · Amlodipino/Valsartán Aurovitas, Amlodipino/Valsartán Cinfamed
  • Finland · Amlodipin/Valsartan Krka, Amlodipin/Valsartan Orion
  • France · Amlodipine/Valsartan Accord, Amlodipine/Valsartan Arrow
  • United Kingdom (Northern Ireland) · Amlodipine / Valsartan Zentiva Pharma
  • Greece · Alvoda, Amlodipine+valsartan Tad
  • Croatia · Dipperam, Vainas
  • Hungary · Amlodipin/Valsartan Krka Pharma, Amlodipin/Valsartan Sandoz
  • Ireland · Amlodipine/Valsartan Clonmel, Amlodipine/Valsartan Krka
  • Iceland · Amlodipine/Valsartan Mylan, Copalia
  • Italy · Amlodipina E Valsartan Doc, Amlodipina E Valsartan Krka Pharma
  • Liechtenstein · Amlodipine/Valsartan Mylan, Copalia
  • Lithuania · Amlodipine/Valsartan Ingen Pharma, Dipperam
  • Luxembourg · Amlodipine/Valsartan Eg
  • Latvia · Wamlox
  • Netherlands · Amlodipine Besylate/Valsartan Aurobindo, Amlodipine/Valsartan Sandoz
  • Norway · Amlodipin/Valsartan Krka, Amlodipine/Valsartan Mylan
  • Portugal · Amlodipina / Valsartan Macleods, Amlodipina + Valsartan Alter
  • Romania · Amlodipină/Valsartan Stada, Bevacomb
  • Sweden · Amlodipin/Valsartan Actavis, Amlodipin/Valsartan Denk
  • Slovenia · Wamlox
  • Slovakia · Amlodipín/Valsartan Sandoz, Wamlox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba5b960b-5246-4f40-befc-8a5a19c00d25
GET /v1/drugs/ba5b960b-5246-4f40-befc-8a5a19c00d25?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "5 mg + 80 mg",
  "packaging": "05909990036707 ¦ Rp ¦ EU/1/06/370/002 ¦ 12737\n14 tabl.\n05909990036776 ¦ Rp ¦ EU/1/06/370/003 ¦ 12773\n28 tabl.\n05909990036783 ¦ Rp ¦ EU/1/06/370/005 ¦ 17472\n56 tabl.\n05909990047505 ¦ Rp ¦ EU/1/06/370/001 ¦ 35937\n7 tabl.\nRp ¦ EU/1/06/370/004 ¦ 85006\n30 tabl.\nRp ¦ EU/1/06/370/006 ¦ 85136\n90 tabl.\nRp ¦ EU/1/06/370/007 ¦ 85201\n98 tabl.\nRp ¦ EU/1/06/370/008 ¦ 85330\n280 tabl.\nRp ¦ EU/1/06/370/025 ¦ 85358\n56 tabl. (56 x 1)\nRp ¦ EU/1/06/370/026 ¦ 85639\n98 tabl. (98 x 1)\nRp ¦ EU/1/06/370/027 ¦ 85671\n280 tabl. (280 x 1)\nRp ¦ EU/1/06/370/034 ¦ 85778\n280 tabl. (4 x 70)\nRp ¦ EU/1/06/370/037 ¦ 134653\n10 tabl.",
  "substance": "Amlodipinum 5 mg + Valsartanum 80 mg",
  "common_name": "Amlodipinum + Valsartanum",
  "pl_product_id": "100171336",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about valsartan and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.